2010

Derré L, Rivals JP, Jandus C, Pastor S, Rimoldi D, Romero P, Michielin O, Olive D, Speiser DE.
BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination.
J Clin Invest., 2010, 120, 157-67.

Bizzini A, Entenza JM, Michielin O, Arnold I, Erni B, Moreillon P.
A single mutation in enzyme I of the sugar phosphotransferase system confers penicillin tolerance to Streptococcus gordonii.
Antimicrob Agents Chemother., 2010, 54, 259-66.

Schupbach T, Zoete V, Tsakam-Sotche B, Michielin O.
Fourier transform convolution integrals applied to generalized Born molecular volume.
J Comput Chem, 2010, 31, 649-59.

Zoete V, Grosdidier A, Cuendet M, Michielin O
Use of the FACTS solvation model for protein-ligand docking calculations. Application to EADock.
J Mol Recognit., 2010, in press.

Röhrig UF, Awad L, Grosdidier A, Larrieu P, Stroobant V, Colau D, Cerundolo V, Simpson AJ, Vogel P, Van den Eynde BJ, Zoete V, Michielin O.
Rational Design of Indoleamine 2,3-Dioxygenase Inhibitors.
J Med Chem., 2010, in press.

Zoete V, Irving MB, Michielin O.
MM-GBSA binding free energy decomposition and T cell Receptor engineering.
J Mol. Recognit., 2010, in press.